Despite the known synergy between AP-1 and oncogenic Ras, few studies have examined the expression of AP-1 proteins in pancreatic cancer, which contains K-Ras mutations in a vast majority of cases [32, 38]. This evidence concerns the gene KRAS and pancreatic neoplasm.